TOKYO – Alexion Pharmaceuticals Inc. is looking for Japanese approval for its drug, asfotase alfa, to treat patients suffering from hypophosphatasia (HPP), an ultra-rare genetic bone disorder. Read More

NEW DELHI – The Indian drug pricing regulator is caught in a bitter wrangle between the pharmaceutical industry and public health organizations over recent and contradictory government orders that first called for a cap on drug prices and then U-turned. Read More

HONG KONG - A multidisciplinary research team from the Singapore-Massachusetts Institute of Technology (MIT) Alliance in Research and Technology (SMART) has identified a unique set of biophysical markers that are predictive for multipotent mesenchymal stromal cells in bone marrow, which should make it easier to develop stem cell-based therapies. Read More

SUZHOU, China – It might be a leadership retreat with golf and sightseeing on the agenda but that only comes after a day of rolling up sleeves and putting heads together to dig into the task of making China a better place for the life sciences industry. Read More

Bionet-Asia Co. Ltd., of Bangkok, provided an update on the company's lead vaccine program at BioJapan 2014, in Yokohama, Japan. The current phase I/II trial in Thailand showed that the vaccine is safe and immunogenic and full results will soon be published in a peer-reviewed journal, Bionet said. Read More